Results 201 to 210 of about 383,105 (350)

The effects of sodium–glucose cotransporter 2 inhibitors on the ‘forgotten’ right ventricle

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1045-1058, April 2025.
Abstract With the progress in diagnosis, treatment and imaging techniques, there is a growing recognition that impaired right ventricular (RV) function profoundly affects the prognosis of patients with heart failure (HF), irrespective of their left ventricular ejection fraction (LVEF).
Liangzhen Qu, Xueting Duan, Han Chen
wiley   +1 more source

Searching for a Solution: A Case Report on Multifocal Ectopic Purkinje-Related Premature Contractions Syndrome. [PDF]

open access: yesMedicina (Kaunas)
Keževičiūtė M   +4 more
europepmc   +1 more source

Dapagliflozin alleviates high‐fat‐induced obesity cardiomyopathy by inhibiting ferroptosis

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1358-1373, April 2025.
Abstract Aim: Dapagliflozin (Dapa) is a novel hypoglycaemic agent with multiple cardiovascular protective effects, and it is widely used in treatment of heart failure patients, but whether it can improve obese phenotype of heart failure and its mechanism is still unclear.
Di Chen   +7 more
wiley   +1 more source

Cardiovascular toxicity induced by immunotherapy in non-small cell lung cancer: a systematic review and meta-analysis of observational studies. [PDF]

open access: yesFront Oncol
Sabaté-Ortega J   +8 more
europepmc   +1 more source

Induction Therapy With Oral Tacrolimus Provides Long‐Term Benefit in Thiopurine‐Naïve Refractory Ulcerative Colitis Patients Despite Low Serum Albumin Levels

open access: yesJGH Open, Volume 9, Issue 4, April 2025.
ABSTRACT Background and Aim Oral tacrolimus is an effective treatment for refractory ulcerative colitis (UC). However, tacrolimus is underutilized because of the difficulties in transitioning to subsequent maintenance therapy and concerns about adverse events.
Shoko Igawa   +9 more
wiley   +1 more source

High risk for life-threatening adverse events of fluoroquinolones in young adults: a large German population-based cohort study. [PDF]

open access: yesBMC Med
Wicherski J   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy